Clinical Trial Update: The Pharmacological Effects of Using Cabozantinib With a Light Breakfast [Phase 2]

View source ↗

Summary

Phase 2 pharmacology study evaluating the effects of taking cabozantinib with a light breakfast in patients with renal cell carcinoma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: dr. Tom van der Hulle | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED